Company Description
Runway Growth Finance Corp. is a business development company specializing investments in senior-secured loans to late stage and growth companies.
It prefers to make investments in companies engaged in the technology, life sciences, healthcare and information services, business services and select consumer services and products sectors.
It prefers to investments in companies engaged in electronic equipment and instruments, systems software, hardware, storage and peripherals and specialized consumer services, application software, healthcare technology, internet software and services, data processing and outsourced services, internet retail, human resources and employment services, biotechnology, healthcare equipment and education services.
It invests in senior secured loans between $10 million and $75 million.
| Country | United States |
| Founded | 2015 |
| IPO Date | Oct 21, 2021 |
| Industry | Asset Management |
| Sector | Financials |
| Employees | 1,050 |
| CEO | David Spreng |
Contact Details
Address: 2061 Avy Avenue, 2nd Floor Menlo Park, California 94025 United States | |
| Phone | 650-645-9751 |
| Website | investors.runwaygrowth.com |
Stock Details
| Ticker Symbol | RWAY |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $14.60 |
| CIK Code | 0001653384 |
| CUSIP Number | 78163D100 |
| ISIN Number | US78163D1000 |
| Employer ID | 47-5049745 |
Key Executives
| Name | Position |
|---|---|
| General Michael Jacob Rovner | Co-Chief Executive Officer and Co-Chief Investment Officer |
| David R. Spreng | Founder, President, Co-Chief Executive Officer, Co- Chief Investment Officer and Director |
| Carmela Thomson | Chief Financial Officer, Treasurer and Corporate Secretary |
| Colleen Corwell | Chief Compliance Officer |
| Thomas B. Raterman | Vice Chairman |
| Ted Cavan | Managing Director of Technology |
| Ryan McCarthy | Managing Director |
| Avisha Khubani C.F.A. | Chief Credit Officer |
| John David Tamas | Managing Director of Healthcare and Life Sciences Investing |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 13, 2026 | 8-K | Current Report |
| Oct 2, 2026 | CERT | Certification by an exchange approving securities for listing |
| Oct 1, 2026 | 8-A12B | Registration of securities |
| Oct 1, 2026 | N-23C-2 | Filing |
| Oct 1, 2026 | 8-K | Current Report |
| Sep 28, 2026 | 424B2 | Prospectus |
| Sep 25, 2026 | 8-K | Current Report |
| Sep 25, 2026 | 424B2 | Prospectus |
| Sep 25, 2026 | 424B2 | Prospectus |
| Sep 25, 2026 | FWP | Free Writing Prospectus |